There are signs that consumers are swapping combustible cigarettes for less harmful HTP, driven in part by the high rates of taxation on combustible products compared to HTP in some markets.[16] HTP sales are even predicted to overtake cigarette sales in countries such as Lithuania and Hungary in the next few years, with consumers in these countries adopting HTP at a faster rate than Japan.[17] we estimate that 69 countries currently allow the sale of HTP HTP are the largest safer nicotine product category by market share, outcompeting even vapes.[18] This is mainly because HTP devices cost more than vapes, and it should be noted that more vapes are sold compared to HTP
Marijuana is therefore a charlatan-weed, an impostor that apes its distant relative tobacco in a shallow and perverse way
++ Or, for an Advanced APM that does not base attribution on E/M services and for which attributed beneficiaries are not a subset of the attribution-eligible beneficiary population based on the requirement to have at least one claim for E/M services furnished by an eligible clinician who is in the APM Entity for any period during the QP Performance Period, the attribution basis determined by CMS based upon the methodology the Advanced APM uses for attribution, which may include a combination of E/M and/or other services
As established in the CY 2024 PFS final rule (88 FR 79425), we continue to estimate burden separately for the simplified and full self-nominations of QCDRs and qualified registries, to more accurately capture the distinct number of estimated respondents and burden per self-nomination for the different processes
This provision also established payment limits for provider-based RHCs in a hospital with less than 50 beds
The findings suggest financial pressure and health concerns are both important drivers of quitting decisions
